Accuray swings to FY27 first-quarter net income of $10.1 million; revenue falls 8% to $86.5 million
ARAY•Accuray reported FY27 first-quarter net income of $10.1 million, including a $59.6 million non-cash gain on debt extinguishment and a $35.4 million goodwill impairment charge. Revenue fell 8% to $86.5 million, and gross product orders dropped 50% to $19.8 million.
1. Quarterly results
Accuray swung to net income of $10.1 million in its FY27 first quarter from a year-earlier loss. Results included a $59.6 million non-cash gain on extinguishment of debt and a $35.4 million non-cash goodwill impairment charge; revenue fell 8% to $86.5 million, while gross product orders dropped 50% to $19.8 million.
2. Business updates
Accuray reached a definitive agreement with RaySearch aimed at accelerating online adaptive radiation therapy, and its collaboration with Samsung NeuroLogica advanced CyberKnife volumetric imaging. Management continues to withhold formal FY27 revenue or adjusted EBITDA guidance, prioritizing stronger product revenue and order performance.
